Drug information for ZOLINZA
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
100MG
Prescription
(Reference Drug)
VORINOSTAT
vorinostat
MERCK
21991
2011-11-17 Letter
2011-11-15 Label
2011-06-17 Letter
2009-11-10 Letter
2009-10-01 Label
2008-07-24 Letter
2008-07-23 Label
2006-11-20 Review
2006-10-13 Letter
2006-10-11 Label
Drug Adverse Effects information for ZOLINZA
Role code
Indications
Reaction
# Reports
PS
GASTRIC CANCER
DECREASED APPETITE
3
PS
GASTRIC CANCER
ENTERITIS
3
PS
GASTRIC CANCER
FATIGUE
3
PS
GASTRIC CANCER
HAEMOGLOBIN DECREASED
3
PS
MYCOSIS FUNGOIDES
DRY MOUTH
2
PS
MYCOSIS FUNGOIDES
GLOSSODYNIA
2
PS
MYCOSIS FUNGOIDES
METASTASES TO LYMPH NODES
2
PS
MYCOSIS FUNGOIDES
PYREXIA
1
PS
MYCOSIS FUNGOIDES
STAPHYLOCOCCAL INFECTION
2
PS
T-CELL LYMPHOMA
DRUG INEFFECTIVE
1
PS
T-CELL LYMPHOMA
RENAL FAILURE
1
SS
ACUTE MYELOID LEUKAEMIA
CARDIAC FAILURE
3
SS
ACUTE MYELOID LEUKAEMIA
DEHYDRATION
6
SS
ACUTE MYELOID LEUKAEMIA
DIARRHOEA
6
SS
ACUTE MYELOID LEUKAEMIA
FEBRILE NEUTROPENIA
3
SS
ACUTE MYELOID LEUKAEMIA
INJECTION SITE REACTION
3
SS
ACUTE MYELOID LEUKAEMIA
PANCYTOPENIA
6
SS
ACUTE MYELOID LEUKAEMIA
PLEURAL EFFUSION
3
SS
ACUTE MYELOID LEUKAEMIA
PNEUMONITIS
6
SS
ACUTE MYELOID LEUKAEMIA
PNEUMOTHORAX
3
SS
ACUTE MYELOID LEUKAEMIA
PYREXIA
9
SS
ACUTE MYELOID LEUKAEMIA
SEPSIS
6
SS
ACUTE MYELOID LEUKAEMIA
SUPRAVENTRICULAR TACHYCARDIA
3
SS
ACUTE MYELOID LEUKAEMIA
WHITE BLOOD CELL COUNT DECREASED
3
Ads by Google